ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.

Maura Rossetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.